342 related articles for article (PubMed ID: 10991938)
21. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of cyclin-dependent kinase inactivation by progestins.
Musgrove EA; Swarbrick A; Lee CS; Cornish AL; Sutherland RL
Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.
Law BK; Chytil A; Dumont N; Hamilton EG; Waltner-Law ME; Aakre ME; Covington C; Moses HL
Mol Cell Biol; 2002 Dec; 22(23):8184-98. PubMed ID: 12417722
[TBL] [Abstract][Full Text] [Related]
24. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
Foster JS; Wimalasena J
Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
[TBL] [Abstract][Full Text] [Related]
25. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
Nakshatri H; Mendonca MS; Bhat-Nakshatri P; Patel NM; Goulet RJ; Cornetta K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1144-53. PubMed ID: 10772965
[TBL] [Abstract][Full Text] [Related]
26. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
Woo MS; Sánchez I; Dynlacht BD
Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
28. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
Planas-Silva MD; Weinberg RA
Mol Cell Biol; 1997 Jul; 17(7):4059-69. PubMed ID: 9199341
[TBL] [Abstract][Full Text] [Related]
30. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
Puri PL; Balsano C; Burgio VL; Chirillo P; Natoli G; Ricci L; Mattei E; Graessmann A; Levrero M
Oncogene; 1997 Mar; 14(10):1171-84. PubMed ID: 9121766
[TBL] [Abstract][Full Text] [Related]
31. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
Teixeira C; Pratt MA
Mol Endocrinol; 1997 Aug; 11(9):1191-202. PubMed ID: 9259311
[TBL] [Abstract][Full Text] [Related]
32. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
[TBL] [Abstract][Full Text] [Related]
33. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
34. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
Mateyak MK; Obaya AJ; Sedivy JM
Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
[TBL] [Abstract][Full Text] [Related]
35. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.
Aikawa T; Segre GV; Lee K
J Biol Chem; 2001 Aug; 276(31):29347-52. PubMed ID: 11384971
[TBL] [Abstract][Full Text] [Related]
37. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
38. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
39. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
40. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
